Evercore ISI Issues Pessimistic Forecast for Enanta Pharmaceuticals (NASDAQ:ENTA) Stock Price

Enanta Pharmaceuticals (NASDAQ:ENTA – Get Free Report) had its price objective lowered by research analysts at Evercore ISI from $20.00 to $12.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage presently has an “outperform” rating on the biotechnology company’s stock. Evercore ISI’s target price indicates a potential upside of 61.07% from […]

Leave a Reply

Your email address will not be published.

Previous post Dear Abby: Help! I need social skills, stat!
Next post Compass Point Initiates Coverage on Cipher Mining (NASDAQ:CIFR)